Chargement en cours...
Time-to-onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis
Oral bisphosphonates reduce fracture risk in osteoporotic patients but are often associated with poor compliance, which may impair their antifracture effects. This post-hoc analysis assessed the time-to-onset and persistence of the antifracture effect of zoledronic acid, a once-yearly bisphosphonate...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3636532/ https://ncbi.nlm.nih.gov/pubmed/22431413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.1605 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|